Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | — | — |
It's Been Over A month , Do I Need to Restart The Series; Initial report received on 29-Jan-2025. A pharmacist reported that a female (age, race, ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and has not received the second dose after more than one month. No medical history or concomitant medications were reported. On 01-Sep-2024, the patient received dose 1 of a hepatitis B vaccine HEPLISAV-B (lot #, expiration date, NDC # 43528-002-05, route, and site not available). At the time of reporting, more than one month after receiving the first dose, the patient had not received the next dose. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.